title: A lack of a proper pharmaceutical presentation of vecuronium used in paediatric anaesthesia may affect drug utilization and costs.
authors.forename: Alejandro A
authors.initials: AA
authors.lastname: Nava-Ocampo
authors.forename: Jorge
authors.initials: J
authors.lastname: Salmerón
authors.forename: Juan
authors.initials: J
authors.lastname: Garduño-Espinosa
authors.forename: Abdiel
authors.initials: A
authors.lastname: Antonio-Ocampo
mesh_terms: D000367:Age Factors; D000758:Anesthesia / Q000191:economics*; D002648:Child; D002675:Child, Preschool; D004304:Dosage Forms; D004363:Drug Utilization / Q000191:economics; D006801:Humans; D007231:Infant, Newborn; D008800:Mexico; D003473:Neuromuscular Nondepolarizing Agents / Q000008:administration & dosage / Q000191:economics; D004364:Pharmaceutical Preparations / Q000008:administration & dosage / Q000191:economics*; D014673:Vecuronium Bromide / Q000008:administration & dosage / Q000191:economics*
chemical_list: D004304:Dosage Forms; D003473:Neuromuscular Nondepolarizing Agents; D004364:Pharmaceutical Preparations; D014673:Vecuronium Bromide